|Numéro de publication||US20050184122 A1|
|Type de publication||Demande|
|Numéro de demande||US 11/111,044|
|Date de publication||25 août 2005|
|Date de dépôt||21 avr. 2005|
|Date de priorité||21 oct. 2002|
|Autre référence de publication||CA2500512A1, CA2662836A1, CN1705462A, EP1555949A2, EP1555949A4, US8460371, US20040172046, WO2004037317A2, WO2004037317A3|
|Numéro de publication||111044, 11111044, US 2005/0184122 A1, US 2005/184122 A1, US 20050184122 A1, US 20050184122A1, US 2005184122 A1, US 2005184122A1, US-A1-20050184122, US-A1-2005184122, US2005/0184122A1, US2005/184122A1, US20050184122 A1, US20050184122A1, US2005184122 A1, US2005184122A1|
|Inventeurs||Edwin Hlavka, Paul Spence|
|Cessionnaire d'origine||Mitralign, Inc.|
|Exporter la citation||BiBTeX, EndNote, RefMan|
|Citations de brevets (98), Référencé par (64), Classifications (26), Événements juridiques (1)|
|Liens externes: USPTO, Cession USPTO, Espacenet|
This application is a continuation of PCT/US03/33382 filed on Oct. 21, 2003 which claims priority of U.S. Provisional Patent Application No. 60/420,095, filed Oct. 21, 2002. The disclosure of each priority application is hereby incorporated by reference herein in its entirety.
The present invention is related to U.S. Pat. No. 6,619,291 entitled “Method and Apparatus for Catheter-Based Annuloplasty,” filed Apr. 24, 2001 and issued Sep. 16, 2003, and to co-pending U.S. patent application Ser. No. 09/866,550, entitled “Method and Apparatus for Catheter-Based Annuloplasty Using Local Plications, which are each incorporated herein by reference in their entireties.
1. Field of Invention
The present invention relates generally to techniques for treating mitral valve insufficiencies such as mitral valve leakage. More particularly, the present invention relates to systems and methods for treating a leaking mitral valve in a minimally invasive manner.
2. Description of the Related Art
Congestive heart failure (CHF), which is often associated with an enlargement of the heart, is a leading cause of death. As a result, the market for the treatment of CHF is becoming increasingly prevalent. For instance, the treatment of CHF is a leading expenditure of Medicare and Medicaid dollars in the United States of America. Typically, the treatment of CHF enables many who suffer from CHF to enjoy an improved quality of life.
Referring initially to
Mitral valve 116, which will be described below in more detail with respect to
Left ventricle 112 includes trabeculae 132 which are fibrous cords of connective tissue that are attached to wall 134 of left ventricle 112. Trabeculae 132 are also attached to an interventricular septum 136 which separates left ventricle 112 from a right ventricle (not shown) of heart 104. Trabeculae 132 are generally located in left ventricle 112 below columnae carnae 128.
Many problems relating to mitral valve 116 may occur and these insufficiencies may cause many types of ailments. Such problems include, but are not limited to, mitral regurgitation. Mitral regurgitation, or leakage, is the backflow of blood from left ventricle 112 into the left atrium 108 due to an imperfect closure of mitral valve 116. That is, leakage often occurs when a gap is created between anterior leaflet 212 and posterior leaflet 216.
In general, a relatively significant gap may exist between anterior leaflet 212 and posterior leaflet 216 (as shown in
Leakage through mitral valve 116 generally causes a heart to operate less efficiently, as the heart must work harder to maintain a proper amount of blood flow therethrough. Leakage through mitral valve 116, or general mitral insufficiency, is often considered to be a precursor to CHF. There are generally different levels of symptoms associated with heart failure. Such levels are classified by the New York Heart Association (NYHA) functional classification system. The levels range from a Class 1 level which is associated with an asymptomatic patient who has substantially no physical limitations to a Class 4 level which is associated with a patient who is unable to carry out any physical activity without discomfort, and has symptoms of cardiac insufficiency even at rest. In general, correcting for mitral valve leakage may be successful in allowing the NYHA classification grade of a patient to be reduced. For instance, a patient with a Class 4 classification may have his classification reduced to Class 3 and, hence, be relatively comfortable at rest.
Treatments used to correct for mitral valve leakage or, more generally, CHF, are typically highly invasive, open-heart surgical procedures. Ventricular assist devices such as artificial hearts may be implanted in a patient whose own heart is failing. The implantation of a ventricular assist device is often expensive, and a patient with a ventricular assist device must be placed on extended anti-coagulant therapy. As will be appreciated by those skilled in the art, anti-coagulant therapy reduces the risk of blood clots being formed, as for example, within the ventricular assist device. While reducing the risks of blood clots associated with the ventricular assist device is desirable, anti-coagulant therapies may increase the risk of uncontrollable bleeding in a patient, e.g., as a result of a fall, which is not desirable.
Rather than implanting a ventricular assist device, bi-ventricular pacing devices similar to pace makers may be implanted in some cases, e.g., cases in which a heart beats inefficiently in a particular asynchronous manner. While the implantation of a bi-ventricular pacing device may be effective, not all heart patients are suitable for receiving a bi-ventricular pacing device. Further, the implantation of a bi-ventricular pacing device is expensive.
Open-heart surgical procedures which are intended to correct for mitral valve leakage, specifically, involve the implantation of replacement valves. Valves from animals, e.g., pigs, may be used to replace a mitral valve 116 in a human. While the use of a pig valve may relatively successfully replace a mitral valve, such valves generally wear out, thereby requiring additional open surgery at a later date. Mechanical valves, which are less likely to wear out, may also be used to replace a leaking mitral valve. However, when a mechanical valve is implanted, there is an increased risk of thromboembolism, and a patient is generally required to undergo extended anti-coagulant therapies.
A less invasive surgical procedure involves heart bypass surgery associated with a port access procedure. For a port access procedure, the heart may be accessed by cutting a few ribs, as opposed to opening the entire chest of a patient. In other words, a few ribs may be cut in a port access procedure, rather than opening a patient's sternum.
One open-heart surgical procedure that is particularly successful in correcting for mitral valve leakage and, in addition, mitral regurgitation, is an annuloplasty procedure. During an annuloplasty procedure, an annuloplasty ring may be implanted on the mitral valve to cause the size of a stretched mitral valve 116 to be reduced to a relatively normal size.
In order for annuloplasty ring 304 to be implanted, a surgeon surgically attaches annuloplasty ring 304 to the mitral valve on the atrial side of the mitral valve. Conventional methods for installing ring 304 require open-heart surgery which involve opening a patient's sternum and placing the patient on a heart bypass machine. As shown in
Once implanted, tissue generally grows over annuloplasty ring 304, and a line of contact between annuloplasty ring 304 and mitral valve 316 will essentially enable mitral valve 316 to appear and function as a normal mitral valve. Although a patient who receives annuloplasty ring 304 may be subjected to anti-coagulant therapies, the therapies are not extensive, as a patient is only subjected to the therapies for a matter of weeks, e.g., until tissue grows over annuloplasty ring 304.
A second surgical procedure which is generally effective in reducing mitral valve leakage involves placing a single edge-to-edge suture in the mitral valve. With reference to
Although the placement of edge-to-edge stitch 404 is generally successful in reducing the amount of mitral valve leakage through gap 408, edge-to-edge stitch 404 is conventionally made through open-heart surgery. In addition, the use of edge-to-edge stitch 404 is generally not suitable for a patient with an enlarged, dilated heart, as blood pressure causes the heart to dilate outward, and may put a relatively large amount of stress on edge-to-edge stitch 404. For instance, blood pressure of approximately 120/80 or higher is typically sufficient to cause the heart to dilate outward to the extent that edge-to-edge stitch 404 may become undone, or tear mitral valve tissue.
Another surgical procedure which reduces mitral valve leakage involves placing sutures along a mitral valve annulus around the posterior leaflet. A surgical procedure which places sutures along a mitral valve with be described with respect to
The placement of sutures 504 along annulus 540, in addition to the tightening of sutures 504, is generally successful in reducing mitral valve leakage. However, the placement of sutures 504 is conventionally accomplished through open-heart surgical procedures. That is, like other conventional procedures, a suture-based annuloplasty procedure is invasive.
While invasive surgical procedures have proven to be effective in the treatment of mitral valve leakage, invasive surgical procedures often have significant drawbacks. Any time a patient undergoes open-heart surgery, there is a risk of infection. Opening the sternum and using a cardiopulmonary bypass machine has also been shown to result in a significant incidence of both short and long term neurological deficits. Further, given the complexity of open-heart surgery, and the significant associated recovery time, people who are not greatly inconvenienced by CHF symptoms, e.g., people at a Class 1 classification, may choose not to have corrective surgery. In addition, people who most need open heart surgery, e.g., people at a Class 4 classification, may either be too frail or too weak to undergo the surgery. Hence, many people who may benefit from a surgically repaired mitral valve may not undergo surgery.
Therefore, what is needed is a minimally invasive treatment for mitral valve leakage. Specifically, what is desired is a method for reducing leakage between an anterior leaflet and a posterior leaflet of a mitral valve that does not require conventional surgical intervention.
The present invention relates to a non-invasive method of performing annuloplasty. Performing an annuloplasty on a mitral valve by accessing the left ventricle of the heart, as for example using a catheter, enables complicated surgical procedures to be avoided when treating mitral valve leakage. Avoiding open-heart surgical procedures generally makes annuloplasty more accessible to patients who may benefit from annuloplasty. As mitral valve leakage is often considered to be an early indicator of congestive heart failure, a minimally invasive annuloplasty procedure that corrects for leakage problems, such as one which involves positioning discrete plications in fibrous tissue around the mitral valve, may greatly improve the quality of life of many patients who might not be suitable for invasive annuloplasty procedures.
According to one aspect of the present invention, a method for performing annuloplasty includes creating a first plication in the tissue near a mitral valve of a heart, using at least a first plication element, and creating a second plication in the tissue near the mitral valve such that the second plication is substantially coupled to the first plication. In one embodiment, the method also includes accessing a left ventricle of the heart to provide the first plication element to the left ventricle, and engaging the first plication element to the tissue near the mitral valve. Engaging the first plication element includes causing the first plication element to substantially pass through a portion of the tissue to substantially anchor the first plication element to the tissue near the mitral valve.
According to another aspect of the present invention, a method for performing annuloplasty includes accessing a heart to provide a plurality of plication elements to the heart. The plurality of plication elements are provided to the heart through a catheter arrangement, and include a first anchor arrangement. The method also includes engaging the first anchor arrangement to tissue near a mitral valve of the heart using the catheter arrangement by causing the first anchor arrangement to substantially pass through the tissue to substantially anchor the first anchor arrangement to the tissue near the mitral valve. Finally, the method includes creating at least a first plication and a second plication using the first anchor arrangement.
In accordance with still another embodiment of the present invention, a method for performing annuloplasty includes accessing an area of a heart to provide a first plication element to the area using a catheter arrangement which has a first portion and a second portion, and substantially anchoring the first portion of the catheter arrangement to tissue near a mitral valve of the heart. The method further includes positioning a tip of the second portion of the catheter arrangement at a first distance from the first portion, and substantially engaging the first anchor to the tissue near the mitral valve of the heart using the second portion of the catheter arrangement. Substantially engaging the first anchor includes causing the first anchor to substantially pass through a portion of the tissue to substantially anchor the first anchor to the tissue near the mitral valve using the second portion of the catheter arrangement. In one embodiment, substantially anchoring the first portion of the catheter arrangement to tissue near the mitral valve of the heart includes positioning the first portion of the catheter arrangement over a guide that is at least temporarily anchored to the tissue near the mitral valve.
These and other advantages of the present invention will become apparent upon reading the following detailed descriptions and studying the various figures of the drawings.
The invention may best be understood by reference to the following description taken in conjunction with the accompanying drawings in which:
Invasive, open-heart surgical procedures are generally effective in the treatment of mitral valve leakage. However, open-heart surgical procedures may be particularly hazardous to some patients, e.g., frail patients or patients who are considered as being very ill, and undesirable to other patients, e.g., patients who are asymptomatic and do not wish to undergo a surgical procedure. As such, open-heart surgical procedures to correct mitral valve leakage or, more generally, mitral valve insufficiency, are not suitable for many patients who would likely benefit from reducing or eliminating the mitral valve leakage.
A catheter-based annuloplasty procedure enables annuloplasty to be performed on a patient without requiring that the patient undergo open-heart surgery, or be placed on cardiopulmonary bypass. Catheters may be introduced into the left ventricle of a heart through the aorta to position a guide wire and plication implants on the ventricular side of a mitral valve, i.e., under a mitral valve. Catheters may also be used to couple the plication implants to fibrous tissue associated with the skeleton of the heart around the mitral valve.
The use of catheters to perform an annuloplasty procedure by delivering and engaging plication implants or structures enables the annuloplasty procedure to be performed without open-heart surgery, and without a bypass procedure. Recovery time associated with the annuloplasty, as well as the risks associated with annuloplasty, may be substantially minimized when the annuloplasty is catheter-based. As a result, annuloplasty becomes a more accessible procedure, since many patients who might previously not have received treatment for mitral valve leakage, e.g., frail patients and asymptomatic patients, may choose to undergo catheter-based annuloplasty.
To begin a catheter-based annuloplasty procedure, a delivery tube and a J-catheter may be inserted into a left ventricle of the heart through the aorta. Inserting the delivery tube and the J-catheter through the aorta enables the left ventricle of the heart to be reached substantially without coming into contact with trabeculae or the cordae tendonae in the left ventricle.
In general, delivery tube 604 is an elongated body which may be formed from a flexible, durable, biocompatible material such as nylon, urethane, or a blend of nylon and urethane, e.g., PEBAX®. Likewise, J-catheter 608, which is also an elongated body, may also be formed from a biocompatible material. A material used to form J-catheter 608 is typically also relatively flexible. In the described embodiment, a tip of J-catheter 608 is rigid enough to allow the tip of J-catheter 608 to maintain a relatively curved shape, e.g., a “J” shape. The curve in J-catheter 608 is configured to facilitate the positioning of a gutter catheter, as will be described below with respect to
Once positioned within left ventricle 624, J-catheter 608 may be rotated within delivery tube 604 such that tip 626 is may enable a gutter catheter fed therethrough to run along the contour of wall 632. Typically, the gutter catheter runs along the contour of wall 632 in an area that is effectively defined between a plane associated with papillary muscles 640, a plane associated with the posterior leaflet of mitral valve 628, cordae tendonae 642, and wall 632. A “gutter” is located in such an area or region and, more specifically, is positioned substantially right under mitral valve 628 where there is a relatively insignificant amount of trabeculae.
With reference to
As shown in
Referring next to
Gutter catheter 704 protrudes through tip 626 of J-catheter 608, and, through steering, essentially forms an arc shape similar to that of mitral valve 728 along the contour of a wall 724 of left ventricle 720 just beneath mitral valve 728, i.e., along the gutter of left ventricle 720. Wall 724 of left ventricle 720 is relatively smooth just beneath mitral valve 728, i.e., generally does not include trabeculae. Hence, inserting catheter assembly 702 through an aortic valve 732 into an upper portion left ventricle 720 allows gutter catheter 704 to be navigated within left ventricle 720 along wall 724 substantially without being obstructed by trabeculae or cordae tendonae.
Gutter catheter 704 generally includes an opening or lumen (not shown) that is sized to accommodate a guide wire through which a guide wire may be inserted. The opening may be located along the central axis of gutter catheter 704, i.e., central axis 730 as shown in
Guide wire 802, which may be formed from a material such as stainless steel or a shape memory material, is generally anchored such that guide wire 802 effectively passes along a large portion of wall 724. Typically, guide wire 802 serves as a track over which a catheter that carries plication structures may be positioned, i.e., a lumen of a catheter that delivers a plication element may pass over guide wire 802. Such a catheter may include a balloon structure (not shown), or an expandable structure, that may facilitate the positioning of local plication structures by pushing the local plication structures substantially against the fibrous tissue around the mitral valve.
Forming local plications causes bunches of the fibrous tissue around the mitral valve to be captured or gathered, thereby causing dilation of the mitral valve to be reduced. In general, the local plications are discrete plications formed in the fibrous tissue around the mitral valve using suture structures or discrete mechanical elements.
Since T-bars 904 or similar structures, when implanted, may cut through tissue 940, pledgets 905 may against a ventricular side tissue 940 to effectively “cushion” T-bars 904. Hence, portions of T-bars 904 are positioned above mitral valve 916, i.e., on an atrial side of mitral valve 916, while pledgets 905 are positioned on the ventricular side of mitral valve 916. It should be appreciated that additional or alternative pledgets may be positioned on the atrial side of mitral valve 916, substantially between tissue 940 and T-bars 904. Catheters which deliver suture structures 904 to an atrial side of mitral valve 916 from a ventricular side of mitral valve 916 will be discussed below with respect to
In the described embodiment, T-bars 904 are coupled such that every two T-bars, e.g., T-bars 904 a, is coupled by a thread, e.g., thread 907 a. Thread 907 a is configured to enable T-bars 904 a to be tensioned together and locked against tissue 940. Locking T-bars 904 a enables tissue 940 to be bunched or slightly gathered, thereby effectively constraining the size, e.g., arc length, of mitral valve 916 by reducing the an arc length associated with tissue 940. In other words, the presence of T-bars 904 which cooperate with thread 907 to function substantially as sutures, allows the size of a gap 908 between an anterior leaflet 920 and a posterior leaflet 918 to be reduced and, further, to be substantially prevented from increasing. As will be appreciated by those skilled in the art, over time, scar tissue (not shown) may form over pledgets 905 and T-bars 904.
Generally, the number of T-bars 904 used to locally bunch or gather tissue 940 may be widely varied. For instance, when substantially only a small, localized regurgitant jet occurs in mitral valve 916, only a small number of T-bars 904 may be implemented in proximity to the regurgitant jet. Alternatively, when the size of gap 908 is significant, and there is a relatively large amount of mitral valve leakage, then a relatively large number of T-bars 904 and, hence, pledgets 905 may be used to reduce the size of gap 908 by reducing the arc length of mitral valve 916. Some pledgets 905 may be arranged to at least partially overlap. To correct for a regurgitant jet that is centralized to only one section of mitral valve 916, T-bars 904 may be implemented as plicating elements near the regurgitant jet, and as reinforcing elements away from the regurgitant jet, e.g., to prevent progression of mitral valve disease from causing a substantial gap to eventually form.
While the coupling of two T-bars 904 a with thread 907 a has been described, it should be understood that the number of T-bars 904 coupled by a thread or threads 907 may vary. For example, if multiple T-bars 904 are coupled by multiple threads 907, then it may be possible to gather more fibrous tissue using fewer total T-bars 904. With reference to
In general, the configurations of suture structures which include T-bars 904 and threads 907 may vary. One embodiment of a suitable suture structure is shown in
Pledgets 905, as will be appreciated by those skilled in the art, may serve as plication anchors for T-bars 904 which essentially function as sutures. That is, pledgets 905 may prevent T-bars 904 from cutting through tissue 940. In general, the configuration of pledgets 905 may vary widely. For example, pledgets 905 may have a substantially tubular form, and may be formed from a material such as surgical, e.g., Dacron, mesh. However, it should be appreciated that pledgets 905 may be formed in substantially any shape and from substantially any material which promotes or supports the growth of scar tissue therethrough. Suitable materials include, but are not limited to silk and substantially any biocompatible porous or fibrous material.
Locking element 1002 may be a one-way locking element, e.g., an element which may not be easily unlocked once it is locked, that is formed from a biocompatible polymer. The configuration of a locking element 1002 may be widely varied. Alternative configurations of locking element 1002 will be described below with respect to
Like locking element 1002, T-bars 904 may also be formed from a biocompatible polymer. Thread 907, which may be coupled to T-bars 904 through tying T-bars 904 to thread 907 or molding T-bars 904 over thread 907, may be formed from substantially any material which is typically used to form sutures. Suitable materials include, but are not limited to, silk, prolene, braided Dacron, and polytetrafluoroethylene (PTFE, or GoreTex).
As mentioned above, the configuration of locking element 1002 may vary. For example, a locking element may include a spring element as shown in
Locking element 1102 includes solid elements 1102 a and a spring element 1102 b. Although solid elements 1102 a may be formed from a biocompatible polymer, solid elements 1102 a may also be formed from material which is typically used to form pledgets. Spring element 1102 b is arranged to be held in an extended position, as shown, while a loop 1114 in thread 1107 is pulled on. Once T-bars 1104 are in contact with tissue 1140, solid elements 1102 a may come into contact with tissue 1140, and spring element 1102 b may contract to create a spring force that pulls solid elements 1102 a toward each other. In other words, once T-bars 1104 are properly positioned against tissue 1140, locking element 1102 may be locked to form a plication or local bunching of tissue 1140.
In one embodiment, the formation of scar tissue on the fibrous tissue which is in proximity to a mitral valve may be promoted before a plication is formed, or before the fibrous tissue is gathered to compensate for mitral valve insufficiency. With reference to
Overmold 1202 c, which may be formed from a resorbable lactide polymer such as PURASORB, which is available from PURAC America of Lincolnshire, Ill., is formed over spring element 1202 b while spring element 1202 b is in an extended position. Overmold 1202 c is arranged to remain intact while scar tissue 1250 forms over solid elements 1202 a. In one embodiment, in order to facilitate the formation of scar tissue, solid elements 1202 a may be formed from material that is porous or fibrous, e.g., “pledget material.”
Once scar tissue is formed over solid elements 1202 a, overmold 1202 c breaks down, e.g., degrades, to expose spring element 1202 b, as shown in
While a loop 1214 of thread 1207 may be allowed to remain extended into a left ventricle of a heart, thread 1207 may be cut, i.e., loop 1214 may be effectively removed, to reduce the amount of loose thread 1207 in the heart. Alternatively, loose thread 1207 may effectively be eliminated by gathering thread 1207 around a cylindrical arrangement (not shown) positioned over locking element 1202. That is, a spool or similar element may be included as a part of suture structure 1200 to enable loose thread 1207 to either be gathered within the spool or gathered around the exterior of the spool.
The use of overmold 1202 c enables anchoring forces which hold T-bars 1204 and locking element 1202 in position to be relatively low, as substantially no significant forces act on tissue 1240 until after scar tissue or tissue ingrowth is created. Once scar tissue is created, and overmold 1202 c has degraded, then spring 1202 b compresses. The anchoring forces generated at this time may be relatively high. However, as scar tissue has been created, the likelihood that T-bars 1204 cut into tissue 1240 at this time is generally relatively low.
As mentioned above, catheters may be used to deliver suture structures into a heart, and to engage the suture structures to tissue around the mitral valve of the heart. One embodiment of a suture structure delivery catheter which is suitable for use in a catheter-based annuloplasty that uses local plications will be described with respect to
Wire 1308 or, more specifically, end 1311 may be used to pull thread 1307 and to push locking element 1302 into position against tissue near the mitral valve. By way of example, end 1311 may pull on thread 1307 until T-bars 1304 contact the tissue. Then, end 1311 may be used to lock locking element 1302 against the tissue and, as a result, create a plication in the tissue to effectively shrink the annulus of the mitral valve.
In order to create additional plications, wire 1308 and, in one embodiment, delivery catheter 1300, may be retracted entirely out of a patient to enable additional T-bars to be loaded onto wire 1308. Once additional T-bars are positioned on wire 1308, wire 1308 may be reinserted into delivery catheter 1300, and delivery catheter 1300 may be used to enable another plication to be created in the tissue which is located near the mitral valve.
With reference to
In one embodiment, catheter arrangement 1360 may require the use of two guide wires to guide each of catheter 1360 a and catheter 1360 b into the gutter of the heart. Alternatively, catheter 1360 a and catheter 1360 b may be arranged such that both catheter 1360 a and catheter 1360 b may be guided through the gutter of the heart through the use of a single guide wire.
Catheter 1360 a is configured to push T-bar 1364 a through tissue near the mitral valve of the heart, and to release T-bar 1364 a once T-bar 1364 a is located on an atrial side of the mitral valve. Similarly, catheter 1360 b is configured to push T-bar 1364 b through the tissue, and to release T-bar 1364 b. T-bars 1364 may be released, for example, when heat is applied to a dielectric associated with catheters 1360 that causes T-bars 1364 to be effectively snapped off. Alternatively, a mechanical mechanism (not shown) that engages T-bars 1364 to catheters 1360 may be disengaged to release T-bars 1354. Once T-bars 1364 are positioned on the atrial side of the mitral valve, catheter 1360 may be used to pull on thread 1367 and to push on locking element 1362.
With reference to
Once the delivery tube and the J-catheter are positioned within the left ventricle, a gutter catheter may be extended through the J-catheter in step 1408. As was discussed above with reference to
In step 1412, a guide wire with an anchoring feature may be delivered through the gutter catheter, e.g., through a lumen or opening in the gutter catheter. The guide wire is delivered through the gutter catheter such that it follows the contour of the gutter catheter against the wall of the left ventricle. After the guide wire is delivered, the anchoring feature of the guide wire is anchored on the wall of the left ventricle in step 1416. Anchoring the guide wire, or otherwise implanting the guide wire, on the wall of the left ventricle enables the guide wire to maintain its position within the left ventricle.
The J-catheter and the gutter catheter are pulled out of the left ventricle through the femoral artery in step 1420, leaving the guide wire anchored within the left ventricle, as was discussed above with respect to
After the T-bar assembly delivery catheter is inserted into the left ventricle, the balloon is inflated in step 1428. Inflating the balloon, e.g., an elastomeric balloon, at a relatively modest pressure using, for example, an air supply coupled to the balloon through the T-bar assembly delivery catheter, serves to enable substantially any catheter which uses the guide wire as a track to be pressed up against the fibrous tissue around the mitral valve. Generally, the inflated balloon substantially occupies the space between the mitral valve and the papillary muscles. In one embodiment, more than one balloon may be inflated in the left ventricle.
Once the balloon is inflated in step 1428. The T-bar assembly delivery catheter effectively delivers T-bars, or similar mechanisms, pledgets, and thread which are arranged to attach or otherwise couple with an annulus of the mitral valve, e.g., the fibrous tissue of the skeleton around the mitral valve, to create plications. Suitable catheters were described above with respect to
Once the plication is created in step 1440, the balloon is generally deflated in step 1442. The T-bar assembly delivery catheter may then be removed through the femoral artery in step 1444. A determination is made in step 1448 after the T-bar assembly delivery catheter is removed as to whether additional plications are to be created. If it is determined that additional plications are to be created, then process flow returns to step 1436 in which the T-bar assembly delivery catheter, which carries a T-bar assembly or suture structure, is reinserted into the femoral artery.
Alternatively, if it is determined in step 1448 that there are no more plications to be created, then process flow proceeds to step 1456 in which the guide wire may be removed. After the guide wire is removed, the delivery tube may be removed in step 1460. Once the delivery tube is removed, the annuloplasty procedure is completed.
In lieu of using suture structures such as T-bar assemblies to create local plications, other elements may also be used to create local plications in fibrous tissue near the mitral valve during an annuloplasty procedure.
The configuration of local plication elements 1522 may be widely varied. For example, local plication elements 1522 may be metallic elements which have spring-like characteristics, or deformable metallic elements which have shape memory characteristics. Alternatively, each local plication element 1522 may be formed from separate pieces which may be physically locked together to form a plication. With reference to
As mentioned above, elements used to create local plications may be created from shape memory materials. The use of a shape memory material to create a plication element allows the plication element to be self-locking.
Once tips 1706 of clip 1704 are pushed through the fibrous tissue near the mitral valve of the heart such that tips 1706 are positioned on an atrial side of the mitral valve, force may be removed from clip 1704. Since clip 1704 is formed from a shape memory material, once force is removed, clip 1704 forms itself into its “rest” state of shape, as shown in
Another discrete self-locking plication element which is suitable for creating a local plication is a clip which may twist from an open position to a closed, or engaged position, once force applied to hold the clip in an open position is removed.
Tine 1806 and tine 1808 first pierce tissue 1830, e.g., the tissue of an annulus of a mitral valve. As tine 1806 and tine 1808 are drawn together to create a plication, thereby reducing the size of gap 1810 by reducing a distance 1820, a bottom portion 1812 of clip element 1800 twists, as for example in a quarter turn, effectively by virtue of shape memory characteristics of clip element 1800. Thus, an effective lock that holds tine 1806 and tine 1808 in a closed position such that tissue 1830 is gathered to form a local plication results.
In lieu of a preloaded clip element, a clip element may include a lock mechanism which engages when force is applied.
When clip element 1850 is delivered into a left ventricle, e.g., using a catheter, clip element 1850 is positioned within the left ventricle such that tip 1856 and tip 1858 are effectively pierced through fibrous tissue 1880 near the mitral valve. After tip 1856 and tip 1858 are positioned substantially on an atrial side of tissue 1880, force may be applied to slider 1862 to move slider 1862 in a y-direction 1870 b over body 1852. As slider moves in y-direction 1870 b away from tapered neck 1854, slider 1862 forces tip 1856 and tip 1858 together close gap 1860, i.e., tip 1856 and tip 1858 move towards each other in an x-direction 1870 a. When tip 1856 and tip 1858 cooperate to close gap 1860, tissue 1880 is gathered within clip element 1850, thereby creating a local plication.
In one embodiment, when slider 1862 is in a closed position such that tip 1856 and tip 1858 cooperate to close gap 1856, slider 1862 may contact tissue 1880. Hence, in order to promote the growth of scar tissue over parts of clip element 1850 or, more specifically, slider 1862, at least a top surface of slider 1862 may be covered with a pledget material, e.g., a mesh which supports the growth of scar tissue therethrough.
Locking elements which create local plications may include elements which have two or more substantially separate pieces which lock together around tissue. An example of a locking element which includes two separate pieces is shown in
A cable tie portion 2010 of locker piece 2004 is configured to be drawn through an opening 2008 which engages cable tie portion 2010. Opening 2008 includes features (not shown) which allow cable tie portion 2010 to be pulled through opening 2008 and locked into position, and which prevent cable tie portion 2010 substantially from being pushed out of opening 2008. Cable tie portion 2010 is locked in opening 2008 when bevels 2012 come into contact and effectively force tines 2006 to clamp down. Once tines 2006 clamp down, and locker piece 2004 is locked against receiver piece 2002, a local plication is formed.
The operation of locking element 2000 will be described with respect to
Once receiver piece 2002 and locker piece 2004 are positioned under tissue 2050 near a location where a plication is to be formed, forces are applied to receiver piece 2002 and locker piece 2004 to push receiver piece 2002 and locker piece 2004 together and effectively through an opening 2058 in top surface 2054 of the catheter, as shown in
After piercing tissue 2050, tines 2006 continue to penetrate and to gather tissue 2050 while receiver piece 2002 and locker piece 2004 are pushed together. As receiver piece 2002 and locker piece 2004 are pushed together, cable tie portion 2010 is inserted into opening 2008 (shown in
In step 2112, a guide wire with an anchoring feature may be delivered through the gutter catheter, e.g., through a lumen or opening in the gutter catheter. The guide wire is delivered through the gutter catheter such that it follows the contour of the gutter catheter against the wall of the left ventricle. After the guide wire is delivered, the anchoring feature of the guide wire is anchored on the wall of the left ventricle in step 2116.
The J-catheter and the gutter catheter are pulled out of the left ventricle through the femoral artery in step 2120, leaving the guide wire anchored within the left ventricle, as was discussed above with respect to
After the local plication is created in step 2136 by engaging tissue using the plication element, the balloon is deflated in step 2138. Upon deflating the balloon, the plication element delivery catheter may be removed through the femoral artery in step 2140. A determination is then made in step 2142 as to whether additional local plications are to be created. That is, it is determined if other plication elements are to be introduced into the left ventricle. If it is determined that additional local plications are to be created, process flow returns to step 2132 in which the plication element delivery catheter, which carries another plication element, is reinserted into the femoral artery.
Alternatively, if it is determined in step 2142 that there are no more local plications to be created, then the indication is that a sufficient number of local plications have already been created. Accordingly, the guide wire may be removed in step 2148, and the delivery tube may be removed in step 2152. After the delivery tube is removed, the annuloplasty procedure is completed.
A catheter which may enable an orthogonal access to a mitral valve may enable the catheter to be more accurately positioned underneath the mitral valve. As discussed above, a catheter may become at least partially tangled in trabeculae which are located in the left ventricle of a heart. As such, inserting a catheter which does not extend too deeply into the left ventricle may prevent significant tangling. Any tangling may impede the efficiency with which the catheter may be positioned beneath a mitral valve. One catheter which may be less likely to become at least partially tangled in trabeculae, while also enabling an orthogonal access to a mitral valve, is an L-shaped catheter, which is shown in
Tip 2208 of L-shaped catheter 2202 may be extended in a straight orientation such that tip 2208 effectively forms an “L” with respect to delivery tube 2201 and the remainder of L-shaped catheter 2202. In one embodiment, as tip 2208 is extended under a mitral valve 2212, a string 2210 or another part, e.g., a wire, that may be coupled to tip 2208 may extend through an opening in delivery tube 2201 as shown in
The use of string 2210 to pull on tip 2208 allows, in cooperation with extending L-shaped catheter 2202, tip 2208 to be moved beneath mitral valve 2212 into desired positions. Hence, desired locations beneath mitral valve 2212 may relatively easily be reached to enable plications (not shown) to be created in the desired locations. In the described embodiment, string 2210 may enable a curve to be created in L-shaped catheter 2202 that is substantially an approximately ninety degree curve.
L-shaped catheter 2202 may be used to create plications in mitral valve 2212 using a variety of different methods. Specifically, tip 2208 of L-shaped catheter 2202 may be temporarily fixed in a position beneath mitral valve 2212, e.g., in a gutter of the heart, during a process of creating a plication in mitral valve 2212. In one embodiment, suction may be used to gather a portion of tissue near mitral valve 2212 either such that a plication may be made in the portion, or such that a temporary anchor point may be created. Suction generally enables tissue to be substantially gathered such that an apparatus, as for example a clip or a similar apparatus, may be put into place to hold the gathered tissue. Alternatively, suction may be used to secure or firmly anchor tip 2208 against mitral valve 2212 such that an anchor for a plication may be deployed with improved accuracy. When tip 2208 is anchored into tissue near mitral valve 2212, an anchor for a plication or a temporary anchor may be more precisely placed, as the position of tip 2208 is effectively fixed.
In lieu of using suction to anchor the tip area of a catheter to tissue near a mitral valve, a wire with a coil which may be extended through a catheter such that the wire may be temporarily anchored into tissue near the mitral valve such that other catheters may track over the wire. For example, a wire with a helical coil or a spiral at the tip may be engaged against tissue by applying force to the tip of the wire, turning the wire such that the helical coil portion of the wire turns through the tissue, the pushing the coil through the tissue.
A wire 2430 with a coiled tip 2432 may generally be used as a temporary anchor which may remain coupled to tissue even after a catheter through which wire 2430 was deployed is retracted. That is, wire 2430 may serve as a track over which other catheters may be “run” to enable a particular position, i.e., a position identified by the location of coiled tip 2432 with respect to the tissue, to be repeatedly accessed or located by catheters.
In general, temporary fixation is a relatively reversible process. By effectively temporarily fixing or anchoring a catheter or a coiled tip of a wire against mitral valve tissue or tissue near a mitral valve, it is relatively easy to position, release, and re-position the wire and, hence, a catheter that tracks over the wire substantially without trauma, and substantially without causing an irreversible action to occur. A temporary anchor may provide a tension or counter-traction force for the application of a permanent anchor. That is, counter-traction on the temporary anchor may be used to provide a tissue penetration force for the permanent anchor. Possible permanent anchors generally include both single anchor points, e.g., applying one T-bar with a second T-bar being needed to for a plications, and dual anchor points, e.g., applying a clip or a staple which creates a plication between its points.
Once a catheter is effectively anchored into position, as for example over a wire such as wire 2430, then anchors which are used to create plications may be deployed. Typically, two anchor points are used to form a single plication.
An incrementor catheter may use tail 2500 as a guide over which the incrementor catheter may be positioned. An incrementor catheter, as shown in
Once first section 2602 is positioned over tail 2500 such that first section 2602 is in relatively close proximity to tissue 2508, a second section 2604 may be extended away from first section 2602, as for example by a nominal separation or distance ‘d,’ as shown in
Additionally, when first section 2602 is temporarily fixed, the position of first section 2602 may be maintained for enough time to perform substantially all desired tests and to withstand forces associated with the desired test. Further, substantially all forces associated with the manipulation of incrementor catheter 2602.
Distance ‘d’ may be substantially any distance, and is typically selected to be a distance which allows a plication created using anchor 2504 and an anchor (not shown) that is to be deployed through second section 2604 to be effectively created. When second section 2604 is used to deploy either a temporary or permanent anchor (not shown), second section 2604 is effectively a working lumen of incrementor catheter 2600.
The location of anchors may generally be verified using a number of technologies which include, but are not limited to, ultrasound techniques, fluoroscopy techniques, and electrical signals. With some of the technologies, the injection of marking agents, e.g., contrast agents for fluoroscopy or microspheres for ultrasound, may increase contrast and promote visibility. Typically, such injections may be into a ventricular space, within mitral valve tissue, or in through the mitral valve tissue into atrial space. It should be appreciated that the verification of locations may further enable a distance ‘d’ between consecutive anchors to be more accurately maintained.
In general, a daisy chain of plications may be created using an incrementor catheter. That is, the incrementor catheter may be used to anchor a series of anchors which are each substantially separated by a distance ‘d.’ Once a daisy chain of anchors is in place in mitral valve tissue, pairs of the anchors may effectively be tied off to create a series or a daisy chain of plications. With reference to
Once first anchor 2802 a and second anchor 2802 b are in place, a locker 2810 a is delivered over tails 2806 a, 2806 b, as shown in
A locker 2810 b may be delivered over tail 2806 b and tail 2806 c, and tail 2806 b may be tensioned, locked, and trimmed as shown in
Instead of using an L-shaped catheter to create anchor points, substantially any other suitable catheter may be used to access tissue near a mitral valve or a mitral valve annulus, e.g., to achieve a substantially orthogonal access to mitral valve tissue. In one embodiment, a suitable catheter may be a hook catheter which effectively includes an approximately 180 degree curve may be used to create anchor points and plications.
Once hook catheter 2900 is positioned or, more specifically, once tip 2902 is positioned near mitral valve tissue 2908, a string 2910 which may be coupled to tip 2902 as shown in
In lieu of using hook catheter 2900 to deploy a temporary anchor, catheter 2900 may instead be used to deploy a more permanent anchor such as a T-bar. As shown in
After T-bar 2940 or, more generally, an anchor is in position, then an incrementor catheter may be snaked or otherwise passed over tail 2942.
The use of an incrementor catheter 2950 allows two T-bars, e.g., T-bar 2940 and T-bar 2980 of
In order to create a plication using T-bars 2940, 2980, a locking bar 2990, as shown in
With reference to
In step 3060, the tip of the catheter may be positioned within the left ventricle. By way of example, the catheter tip may be positioned at a level that is just inferior to the level of the mitral valve annulus, and the catheter segment that includes the hook shape may be rotated such that it lies against either the anterior or posterior aspect of the aortic outflow tract, depending upon which aspect is to be treated. In one embodiment, the distal catheter segment is aligned such that when extended, the tip of the catheter may point towards one of the entrances to the gutter of the heart. The entrances to the gutter of the heart may include substantially any relatively clear entrance to the gutter with respect to the leaflets of the heart, as for example a medial P1 location, a mid P2 location, or a lateral P3 location.
After the tip of the catheter is positioned, the tip of the catheter may be hooked into the gutter in step 3080. Hooking the catheter tip into the gutter may include repeatedly extending the retrograde tip to increase the gap between the tip and the proximal segment of the catheter, retracting the entire catheter and sensing engagement of the tip with the gutter, and, if necessary, one again positioning the tip of the catheter in the left ventricle before rehooking the tip.
Once the catheter tip is hooked into the gutter, the location of the tip is confirmed in step 3100. Confirming the location of the tip may include, but is not limited to, as previously mentioned, sensing electrical signals of the heart, fluoroscopy with or without the injection of contrast, and ultrasound with or without the injection of microspheres. When the tip location is confirmed, a temporary anchor may be attached in step 3120. The temporary anchor may be a helical coil, e.g., helical coil 2432 of
In the described embodiment, after the temporary anchor is attached, the location of the temporary anchor is confirmed in step 3140. Methods used to confirm the location of the temporary anchor may be the same as methods used to confirm the location of a catheter tip, and may also include injecting contrast or microspheres into tissue or through tissue to the atrial space above a mitral valve.
A permanent anchor is attached in step 3160 using the connection to the temporary anchor as a guide. The permanent anchor may be attached to the same location, and may provide a counter-traction force for tissue engagement. Like the temporary anchor, the permanent anchor generally includes a tail.
Once a permanent anchor is in place, an incrementor catheter is delivered into the heart in step 3180. In general, the incrementor catheter is delivered in a closed configuration to the location of the first anchor, e.g., the permanent anchor attached in step 3160, by tracking a first section of the incrementor catheter over the tail of the first anchor. After the incrementor catheter is delivered, the incrementor catheter may be deployed in step 3200 to create a nominal distance or gap between the first anchor location and the working lumen, e.g., a second section, of the incrementor catheter. Then, in step 3220, a second permanent anchor may be applied at the nominal distance from the first permanent anchor. It should be appreciated that temporary anchors may be used to facilitate the positioning of the second permanent anchor. Applying the second permanent anchor typically includes retracting the incrementor catheter once the second permanent anchor is anchored into a desired location.
After both the first permanent anchor and the second permanent anchor are applied, a locker is delivered into the heart in step 3240. Delivering the locker generally includes tracking the locker or locking device over the two tails of the first and the second permanent anchors. The locker may be fixed into position by applying tension to the locker to create a plication substantially between the two permanent anchors.
Once the locker has been tensioned, the tails of the anchors may be severed, and the process of creating a plication is completed. It should be appreciated that, in one embodiment, steps 3180 to 3260 may generally be repeated to create a daisy chain of interlocking plications.
Although only a few embodiments of the present invention have been described, it should be understood that the present invention may be embodied in many other specific forms without departing from the spirit or the scope of the present invention. By way of example, methods of introducing plication elements or suture structures into the left ventricle to correct for mitral valve leakage, or mitral valve insufficiency, may be applied to introducing plication elements or suture structures which correct for leakage in other valves. For instance, the above-described procedure may be adapted for use in repair a leaking valve associated with a right ventricle.
While creating local plications in fibrous tissue associated with the mitral valve of the heart has generally been described, the plications may also be created in other types of tissue which are near, around, in proximity to, or include the mitral valve. As will be appreciated by those skilled in the art, other tissues to which plications may be formed that are near, around, in proximity to, or include the mitral valve include tissues associated with the coronary sinus, tissues associated with the myocardium, or tissues associated with the wall of the left ventricle. In one embodiment, a plication may be substantially directly formed in the leaflets of the mitral valve.
It should be understood that although a guide wire has been described as including an anchoring tip to anchor the guide wire to a wall of the left ventricle, a guide wire may be anchored with respect to the left ventricle in substantially any suitable manner. By way of example, a guide wire may include an anchoring feature which is located away from the tip of the guide wire. In addition, a guide wire may more generally be any suitable guiding element which is configured to facilitate the positioning of an implant.
While access to the gutter of the left ventricle has been described as being associated with a minimally invasive catheter annuloplasty procedure in which local plications are formed, it should be understood that the gutter of the left ventricle may also be accessed, e.g., for an annuloplasty procedure, as a part of a surgical procedure in which local plications are formed. For instance, the aorta of a heart may be accessed through an open chest surgical procedure before a catheter is inserted into the aorta to reach the left ventricle. Alternatively, suture structures or plications elements may be introduced on a ventricular side of a mitral valve through a ventricular wall which is accessed during an open chest surgical procedure.
Pledgets have been described as being used in conjunction with, or as a part of, suture structures to facilitate the growth of scar tissue as a result of an annuloplasty procedure. It should be appreciated, however, that the use of pledgets is optional. In addition, although pledgets have generally not been described as being used with clip elements which create local plications, it should be understood that pledgets may also be implemented with respect to clip elements. By way of example, a clip element which includes tines may be configured such that the tines pierce through pledgets before engaging tissue without departing from the spirit or the scope of the present invention.
When a clip element has tines that are arranged to pierce through a pledget before engaging tissue, the pledget may be of a hollow, substantially cylindrical shape that enables the pledget be delivered to a left ventricle over a guide wire positioned in the gutter of the left ventricle. The clip element may then be delivered by a catheter through the pledget. A substantially cylindrically shaped, hollow pledget which is to be used with a suture structure may also be delivered over a guide wire, and the suture structure may then be delivered through the pledget. Delivering the suture structure through the pledget may enable a loop of thread that remains after the suture structure is locked into place to remain substantially within the pledget.
The configuration of clip elements may generally vary widely. Specifically, the shape of clip elements, the size of clip elements, and the materials from which the clip elements are formed may be widely varied. For instance, in addition to clip elements that are formed from shape memory material, preloaded, or self-locking using mechanical structures, clip elements may also be formed from thermally expandable materials. That is, a clip may be formed such that it is in an open or flat position when delivered into a left ventricle. Such a clip may have an outer or “bottom” element that has a relatively high coefficient of thermal expansion, and an inner or “top” element that deforms under the load generated by the outer element when heat is applied to cause the outer element to bend. Such a clip, once bent or deformed through the application of heat, may pierce tissue. When more heat is applied, the clip may bend more such that tissue is engaged between ends or sides of the clip to create a local plication. In such a system, the inner material may be arranged to maintain its deformed shape once heat is no longer applied, and the heat may be applied through a catheter.
Suture structures and plication elements have been described as being used to correct for mitral valve insufficiency. In general, suture structures and plication elements may also be used to essentially prevent the onset of mitral valve insufficiency. That is, local plications may be created to effectively stem the progression of mitral valve insuffiency be reinforcing the perimeter of the annulus around the mitral valve.
While suture structures that include T-bars, thread, and locking elements, and are delivered to a left ventricle using a catheter, may be used to form discrete plications in fibrous tissue around the mitral valve, it should be appreciated that sutures may also be sewn into the fibrous tissue. For example, a catheter which is inserted into the left ventricle through the aorta may be configured to sew sutures into the fibrous tissue using mechanisms carried by the catheter. Such sutures that are sewn into the fibrous tissue may be sewn in any conventional orientation, e.g., in an arc along the perimeter of the posterior leaflet of the mitral valve.
Suture structures that include T-bars have generally been described as including two T-bars which are located at ends of a thread, with a locking element and pledgets located therebetween, as shown, for example, in
In general, the use of a single element type to create local plications during an annuloplasty procedure has been described. It should be understood that in one embodiment, different element types may be used in a single annuloplasty procedure. For instance, both clip elements and suture elements may be used to create plications during a single annuloplasty procedure. Alternatively, different types of clip elements or different types of suture elements may be used during a particular annuloplasty procedure.
The steps associated with performing a catheter-based annuloplasty may be widely varied. Steps may generally be added, removed, reordered, and altered without departing from the spirit or the scope of the present invention. Therefore, the present examples are to be considered as illustrative and not restrictive, and the invention is not to be limited to the details given herein, but may be modified within the scope of the appended claims.
|Brevet cité||Date de dépôt||Date de publication||Déposant||Titre|
|US654766 *||7 déc. 1898||31 juil. 1900||Gustav Selle||Production of colored photographs.|
|US3674014 *||21 oct. 1970||4 juil. 1972||Astra Meditec Ab||Magnetically guidable catheter-tip and method|
|US3794041 *||30 nov. 1971||26 févr. 1974||Yeda Res & Dev||Gastrointestinal catheter|
|US4042979 *||12 juil. 1976||23 août 1977||Angell William W||Valvuloplasty ring and prosthetic method|
|US4809713 *||28 oct. 1987||7 mars 1989||Joseph Grayzel||Catheter with magnetic fixation|
|US4917689 *||2 déc. 1988||17 avr. 1990||Smiths Industries Public Limited Company||Ostomy bag with support ring|
|US4945912 *||25 nov. 1988||7 août 1990||Sensor Electronics, Inc.||Catheter with radiofrequency heating applicator|
|US5041130 *||30 nov. 1989||20 août 1991||Baxter International Inc.||Flexible annuloplasty ring and holder|
|US5104407 *||20 sept. 1990||14 avr. 1992||Baxter International Inc.||Selectively flexible annuloplasty ring|
|US5201880 *||27 janv. 1992||13 avr. 1993||Pioneering Technologies, Inc.||Mitral and tricuspid annuloplasty rings|
|US5306234 *||23 mars 1993||26 avr. 1994||Johnson W Dudley||Method for closing an atrial appendage|
|US5306296 *||21 août 1992||26 avr. 1994||Medtronic, Inc.||Annuloplasty and suture rings|
|US5429131 *||25 févr. 1994||4 juil. 1995||The Regents Of The University Of California||Magnetized electrode tip catheter|
|US5450860 *||31 août 1993||19 sept. 1995||W. L. Gore & Associates, Inc.||Device for tissue repair and method for employing same|
|US5593424 *||10 août 1994||14 janv. 1997||Segmed, Inc.||Apparatus and method for reducing and stabilizing the circumference of a vascular structure|
|US5607471 *||21 août 1995||4 mars 1997||Jacques Seguin||Prosthetic ring for heart surgery|
|US5623943 *||12 août 1992||29 avr. 1997||Scimed Life Systems, Inc.||Magnetic medical shaft movement control device and method|
|US5640955 *||14 févr. 1995||24 juin 1997||Daig Corporation||Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach|
|US5669919 *||16 août 1996||23 sept. 1997||Medtronic, Inc.||Annuloplasty system|
|US5706827 *||14 août 1996||13 janv. 1998||Scimed Life Systems, Inc.||Magnetic lumen catheter|
|US5716367 *||18 oct. 1996||10 févr. 1998||Nissho Corporation||Catheter assembly for intracardiac suture|
|US5716397 *||6 déc. 1996||10 févr. 1998||Medtronic, Inc.||Annuloplasty device with removable stiffening element|
|US5716399 *||6 oct. 1995||10 févr. 1998||Cardiomend Llc||Methods of heart valve repair|
|US5776080 *||2 mai 1997||7 juil. 1998||Scimed Life Systems, Inc.||Shaft movement control apparatus|
|US5776189 *||5 mars 1997||7 juil. 1998||Khalid; Naqeeb||Cardiac valvular support prosthesis|
|US5813996 *||21 déc. 1995||29 sept. 1998||Scimed Life Systems, Inc.||Guide wire extension system with magnetic coupling|
|US5860920 *||16 sept. 1997||19 janv. 1999||Ep Technologies, Inc.||Systems for locating and ablating accessory pathways in the heart|
|US5868733 *||14 avr. 1995||9 févr. 1999||Daig Corporation||Guiding introducer system for use in the treatment of accessory pathways around the mitral valve using a retrograde approach|
|US5888240 *||3 déc. 1996||30 mars 1999||Baxter International Inc.||Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accomodate patient growth|
|US5906579 *||14 août 1997||25 mai 1999||Smith & Nephew Endoscopy, Inc.||Through-wall catheter steering and positioning|
|US5928224 *||24 janv. 1997||27 juil. 1999||Hearten Medical, Inc.||Device for the treatment of damaged heart valve leaflets and methods of using the device|
|US5931818 *||12 nov. 1997||3 août 1999||Stereotaxis, Inc.||Method of and apparatus for intraparenchymal positioning of medical devices|
|US6015414 *||29 août 1997||18 janv. 2000||Stereotaxis, Inc.||Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter|
|US6029671 *||22 mai 1996||29 févr. 2000||Heartport, Inc.||System and methods for performing endovascular procedures|
|US6068637 *||29 août 1996||30 mai 2000||Cedar Sinai Medical Center||Method and devices for performing vascular anastomosis|
|US6071292 *||28 juin 1997||6 juin 2000||Transvascular, Inc.||Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures|
|US6099460 *||28 avr. 1998||8 août 2000||Denker; Stephen||Electromagnetic heart assist technique and apparatus|
|US6102945 *||16 oct. 1998||15 août 2000||Sulzer Carbomedics, Inc.||Separable annuloplasty ring|
|US6173199 *||5 mai 1998||9 janv. 2001||Syncro Medical Innovations, Inc.||Method and apparatus for intubation of a patient|
|US6190353 *||11 oct. 1996||20 févr. 2001||Transvascular, Inc.||Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures|
|US6210432 *||30 juin 1999||3 avr. 2001||Jan Otto Solem||Device and method for treatment of mitral insufficiency|
|US6231587 *||11 mars 1999||15 mai 2001||Transvascular, Inc.||Devices for connecting anatomical conduits such as vascular structures|
|US6267781 *||9 oct. 1999||31 juil. 2001||Quantum Therapeutics Corp.||Medical device and methods for treating valvular annulus|
|US6269819 *||25 juin 1998||7 août 2001||The Trustees Of Columbia University In The City Of New York||Method and apparatus for circulatory valve repair|
|US6287317 *||5 avr. 2000||11 sept. 2001||Transvascular, Inc.||Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures|
|US6352543 *||29 avr. 2000||5 mars 2002||Ventrica, Inc.||Methods for forming anastomoses using magnetic force|
|US6385472 *||10 sept. 1999||7 mai 2002||Stereotaxis, Inc.||Magnetically navigable telescoping catheter and method of navigating telescoping catheter|
|US6401720 *||4 oct. 1999||11 juin 2002||John H. Stevens||Method and apparatus for thoracoscopic intracardiac procedures|
|US6402781 *||31 janv. 2000||11 juin 2002||Mitralife||Percutaneous mitral annuloplasty and cardiac reinforcement|
|US6447522 *||18 juin 2001||10 sept. 2002||C. R. Bard, Inc.||Implant delivery system|
|US6524303 *||8 sept. 2000||25 févr. 2003||Stereotaxis, Inc.||Variable stiffness magnetic catheter|
|US6530952 *||21 déc. 2000||11 mars 2003||The Cleveland Clinic Foundation||Bioprosthetic cardiovascular valve system|
|US6537314 *||30 janv. 2001||25 mars 2003||Ev3 Santa Rosa, Inc.||Percutaneous mitral annuloplasty and cardiac reinforcement|
|US6542766 *||19 juil. 2001||1 avr. 2003||Andrew F. Hall||Medical devices adapted for magnetic navigation with magnetic fields and gradients|
|US6544230 *||31 mars 1999||8 avr. 2003||Transvascular, Inc.||Catheters, systems and methods for percutaneous in situ arterio-venous bypass|
|US6562019 *||20 sept. 1999||13 mai 2003||Stereotaxis, Inc.||Method of utilizing a magnetically guided myocardial treatment system|
|US6565562 *||10 sept. 2001||20 mai 2003||Baylis Medical Company Inc.||Method for the radio frequency perforation and the enlargement of a body tissue|
|US6594517 *||12 mai 1999||15 juil. 2003||Robin Medical, Inc.||Method and apparatus for generating controlled torques on objects particularly objects inside a living body|
|US6619291 *||24 avr. 2001||16 sept. 2003||Edwin J. Hlavka||Method and apparatus for catheter-based annuloplasty|
|US6626930 *||1 mai 2000||30 sept. 2003||Edwards Lifesciences Corporation||Minimally invasive mitral valve repair method and apparatus|
|US6676702 *||14 mai 2001||13 janv. 2004||Cardiac Dimensions, Inc.||Mitral valve therapy assembly and method|
|US6702825 *||11 juil. 2001||9 mars 2004||Ev3 Sunnyvale, Inc.||Anastomosis catheter|
|US6718985 *||25 mai 2001||13 avr. 2004||Edwin J. Hlavka||Method and apparatus for catheter-based annuloplasty using local plications|
|US6945978 *||15 nov. 2002||20 sept. 2005||Advanced Cardiovascular Systems, Inc.||Heart valve catheter|
|US20020029080 *||19 oct. 2001||7 mars 2002||Myocor, Inc.||Valve to myocardium tension members device and method|
|US20020128708 *||8 déc. 2000||12 sept. 2002||Northrup William F.||Annuloplasty system|
|US20030018358 *||3 juil. 2002||23 janv. 2003||Vahid Saadat||Apparatus and methods for treating tissue|
|US20030078671 *||24 oct. 2002||24 avr. 2003||Lesniak Jeanne M.||Prevention of myocardial infarction induced ventricular expansion and remodeling|
|US20030120340 *||26 déc. 2001||26 juin 2003||Jan Liska||Mitral and tricuspid valve repair|
|US20040019378 *||18 juil. 2003||29 janv. 2004||Hlavka Edwin J.||Method and apparatus for performing catheter-based annuloplasty|
|US20040024414 *||1 juil. 2003||5 févr. 2004||Downing Stephen W.||Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart|
|US20040030382 *||5 août 2003||12 févr. 2004||Evalve, Inc.||Methods and apparatus for cardiac valve repair|
|US20040039442 *||7 août 2003||26 févr. 2004||Evalve, Inc.||Methods and apparatus for cardiac valve repair|
|US20040092962 *||19 mai 2003||13 mai 2004||Evalve, Inc., A Delaware Corporation||Multi-catheter steerable guiding system and methods of use|
|US20040127983 *||7 oct. 2003||1 juil. 2004||Myocor, Inc.||Valve to myocardium tension members device and method|
|US20040133063 *||12 déc. 2003||8 juil. 2004||Myocor||Methods and devices for improving cardiac function in hearts|
|US20040147958 *||25 sept. 2003||29 juil. 2004||Usgi Medical||Apparatus and methods for forming and securing gastrointestinal tissue folds|
|US20040152947 *||23 janv. 2004||5 août 2004||Schroeder Richard F.||Methods and devices for improving mitral valve function|
|US20040162568 *||12 déc. 2003||19 août 2004||Usgi Medical||Apparatus and methods for forming and securing gastrointestinal tissue folds|
|US20040167620 *||26 févr. 2004||26 août 2004||Medtentia||Annuloplasty devices and related heart valve repair methods|
|US20040172046 *||21 oct. 2003||2 sept. 2004||Hlavka Edwin J.||Method and apparatus for performing catheter-based annuloplasty using local plications|
|US20040193191 *||19 déc. 2003||30 sept. 2004||Guided Delivery Systems, Inc.||Devices and methods for heart valve repair|
|US20050033446 *||7 avr. 2004||10 févr. 2005||Evalve, Inc. A California Corporation||Methods and apparatus for cardiac valve repair|
|US20050049681 *||19 mai 2004||3 mars 2005||Secant Medical, Llc||Tissue distention device and related methods for therapeutic intervention|
|US20050055009 *||5 sept. 2003||10 mars 2005||Codman & Shurtleff, Inc.||Method and apparatus for managing normal pressure hydrocephalus|
|US20050055087 *||4 sept. 2003||10 mars 2005||Guided Delivery Systems, Inc.||Devices and methods for cardiac annulus stabilization and treatment|
|US20050065550 *||27 juil. 2004||24 mars 2005||Guided Delivery Systems, Inc.||Delivery devices and methods for heart valve repair|
|US20050065601 *||10 nov. 2004||24 mars 2005||Coalescent Surgical, Inc.||Annuloplasty apparatus and methods|
|US20050075723 *||7 mai 2004||7 avr. 2005||Myocor, Inc.||Methods and devices for improving mitral valve function|
|US20050107810 *||10 févr. 2004||19 mai 2005||Guided Delivery Systems, Inc.||Devices and methods for heart valve repair|
|US20050107812 *||27 juil. 2004||19 mai 2005||Guided Delivery Systems, Inc.||Delivery devices and methods for heart valve repair|
|US20050107871 *||30 mars 2004||19 mai 2005||Fidel Realyvasquez||Apparatus and methods for valve repair|
|US20050119523 *||27 août 2004||2 juin 2005||Guided Delivery Systems, Inc.||Cardiac visualization devices and methods|
|US20050143811 *||2 déc. 2004||30 juin 2005||Fidel Realyvasquez||Methods and apparatus for mitral valve repair|
|US20050148815 *||28 janv. 2005||7 juil. 2005||Myocor, Inc.||Transventricular implant tools and devices|
|US20050149014 *||15 févr. 2005||7 juil. 2005||Quantumcor, Inc.||Cardiac valve leaflet attachment device and methods thereof|
|US20050159810 *||15 janv. 2004||21 juil. 2005||Farzan Filsoufi||Devices and methods for repairing cardiac valves|
|US20060142756 *||3 nov. 2005||29 juin 2006||Baylis Medical Company Inc.||Method of surgical perforation via the delivery of energy|
|Brevet citant||Date de dépôt||Date de publication||Déposant||Titre|
|US7666193||27 juil. 2004||23 févr. 2010||Guided Delivery Sytems, Inc.||Delivery devices and methods for heart valve repair|
|US7666224||7 juil. 2005||23 févr. 2010||Edwards Lifesciences Llc||Devices and methods for heart valve treatment|
|US7670368||2 mars 2010||Boston Scientific Scimed, Inc.||Venous valve apparatus, system, and method|
|US7678145||1 juil. 2005||16 mars 2010||Edwards Lifesciences Llc||Devices and methods for heart valve treatment|
|US7682385||3 juil. 2006||23 mars 2010||Boston Scientific Corporation||Artificial valve|
|US7722666||15 avr. 2005||25 mai 2010||Boston Scientific Scimed, Inc.||Valve apparatus, system and method|
|US7753858||27 juil. 2004||13 juil. 2010||Guided Delivery Systems, Inc.||Delivery devices and methods for heart valve repair|
|US7753922||4 sept. 2003||13 juil. 2010||Guided Delivery Systems, Inc.||Devices and methods for cardiac annulus stabilization and treatment|
|US7753924||27 juil. 2004||13 juil. 2010||Guided Delivery Systems, Inc.||Delivery devices and methods for heart valve repair|
|US7758637||27 juil. 2004||20 juil. 2010||Guided Delivery Systems, Inc.||Delivery devices and methods for heart valve repair|
|US7766812||14 avr. 2006||3 août 2010||Edwards Lifesciences Llc||Methods and devices for improving mitral valve function|
|US7776053 *||12 déc. 2006||17 août 2010||Boston Scientific Scimed, Inc.||Implantable valve system|
|US7780627||16 juil. 2007||24 août 2010||Boston Scientific Scimed, Inc.||Valve treatment catheter and methods|
|US7780722||7 févr. 2005||24 août 2010||Boston Scientific Scimed, Inc.||Venous valve apparatus, system, and method|
|US7799038||20 janv. 2006||21 sept. 2010||Boston Scientific Scimed, Inc.||Translumenal apparatus, system, and method|
|US7854755||1 févr. 2005||21 déc. 2010||Boston Scientific Scimed, Inc.||Vascular catheter, system, and method|
|US7854761||19 déc. 2003||21 déc. 2010||Boston Scientific Scimed, Inc.||Methods for venous valve replacement with a catheter|
|US7878966||4 févr. 2005||1 févr. 2011||Boston Scientific Scimed, Inc.||Ventricular assist and support device|
|US7883538||20 sept. 2005||8 févr. 2011||Guided Delivery Systems Inc.||Methods and devices for termination|
|US7892276||21 déc. 2007||22 févr. 2011||Boston Scientific Scimed, Inc.||Valve with delayed leaflet deployment|
|US7922762||3 juin 2008||12 avr. 2011||Guided Delivery Systems Inc.||Devices and methods for cardiac annulus stabilization and treatment|
|US7951189||27 juil. 2009||31 mai 2011||Boston Scientific Scimed, Inc.||Venous valve, system, and method with sinus pocket|
|US7967853||5 févr. 2008||28 juin 2011||Boston Scientific Scimed, Inc.||Percutaneous valve, system and method|
|US8002824||23 juil. 2009||23 août 2011||Boston Scientific Scimed, Inc.||Cardiac valve, system, and method|
|US8012198||6 sept. 2011||Boston Scientific Scimed, Inc.||Venous valve, system, and method|
|US8066766||20 août 2007||29 nov. 2011||Guided Delivery Systems Inc.||Methods and devices for termination|
|US8128681||19 déc. 2003||6 mars 2012||Boston Scientific Scimed, Inc.||Venous valve apparatus, system, and method|
|US8133270||8 janv. 2008||13 mars 2012||California Institute Of Technology||In-situ formation of a valve|
|US8137394||14 janv. 2011||20 mars 2012||Boston Scientific Scimed, Inc.||Valve with delayed leaflet deployment|
|US8142493||22 juil. 2008||27 mars 2012||Mitralign, Inc.||Method of heart valve repair|
|US8226711||1 juil. 2005||24 juil. 2012||Edwards Lifesciences, Llc||Valve to myocardium tension members device and method|
|US8287555||19 déc. 2003||16 oct. 2012||Guided Delivery Systems, Inc.||Devices and methods for heart valve repair|
|US8287557||20 août 2007||16 oct. 2012||Guided Delivery Systems, Inc.||Methods and devices for termination|
|US8343173||1 janv. 2013||Guided Delivery Systems Inc.||Delivery devices and methods for heart valve repair|
|US8348999||13 févr. 2012||8 janv. 2013||California Institute Of Technology||In-situ formation of a valve|
|US8382829||9 mars 2009||26 févr. 2013||Mitralign, Inc.||Method to reduce mitral regurgitation by cinching the commissure of the mitral valve|
|US8388680||18 oct. 2006||5 mars 2013||Guided Delivery Systems, Inc.||Methods and devices for catheter advancement and delivery of substances therethrough|
|US8414641||2 mars 2012||9 avr. 2013||Boston Scientific Scimed, Inc.||Valve with delayed leaflet deployment|
|US8460365||27 mai 2011||11 juin 2013||Boston Scientific Scimed, Inc.||Venous valve, system, and method with sinus pocket|
|US8460371||21 oct. 2003||11 juin 2013||Mitralign, Inc.||Method and apparatus for performing catheter-based annuloplasty using local plications|
|US8470023||22 juin 2011||25 juin 2013||Boston Scientific Scimed, Inc.||Percutaneous valve, system, and method|
|US8512399||28 déc. 2009||20 août 2013||Boston Scientific Scimed, Inc.||Valve apparatus, system and method|
|US8641727||3 juin 2008||4 févr. 2014||Guided Delivery Systems, Inc.||Devices and methods for heart valve repair|
|US8672997||24 avr. 2012||18 mars 2014||Boston Scientific Scimed, Inc.||Valve with sinus|
|US8721717||27 janv. 2012||13 mai 2014||Boston Scientific Scimed, Inc.||Venous valve apparatus, system, and method|
|US8790367||5 févr. 2009||29 juil. 2014||Guided Delivery Systems Inc.||Multi-window guide tunnel|
|US8795298||9 oct. 2009||5 août 2014||Guided Delivery Systems Inc.||Tether tensioning devices and related methods|
|US8828079||26 juil. 2007||9 sept. 2014||Boston Scientific Scimed, Inc.||Circulatory valve, system and method|
|US8845723||13 mars 2007||30 sept. 2014||Mitralign, Inc.||Systems and methods for introducing elements into tissue|
|US8864822||13 mars 2007||21 oct. 2014||Mitralign, Inc.||Devices and methods for introducing elements into tissue|
|US8911461||5 nov. 2007||16 déc. 2014||Mitralign, Inc.||Suture cutter and method of cutting suture|
|US8932349||22 août 2011||13 janv. 2015||Boston Scientific Scimed, Inc.||Cardiac valve, system, and method|
|US8951285||5 juil. 2005||10 févr. 2015||Mitralign, Inc.||Tissue anchor, anchoring system and methods of using the same|
|US8951286||19 nov. 2008||10 févr. 2015||Mitralign, Inc.||Tissue anchor and anchoring system|
|US8979923||24 sept. 2004||17 mars 2015||Mitralign, Inc.||Tissue fastening systems and methods utilizing magnetic guidance|
|US9028542||6 sept. 2011||12 mai 2015||Boston Scientific Scimed, Inc.||Venous valve, system, and method|
|US9072513||6 août 2008||7 juil. 2015||Guided Delivery Systems Inc.||Methods and devices for termination|
|US20040019378 *||18 juil. 2003||29 janv. 2004||Hlavka Edwin J.||Method and apparatus for performing catheter-based annuloplasty|
|US20050119735 *||24 sept. 2004||2 juin 2005||Spence Paul A.||Tissue fastening systems and methods utilizing magnetic guidance|
|US20050125011 *||31 janv. 2005||9 juin 2005||Spence Paul A.||Tissue fastening systems and methods utilizing magnetic guidance|
|US20050137700 *||24 sept. 2004||23 juin 2005||Spence Paul A.||Tissue fastening systems and methods utilizing magnetic guidance|
|US20050267571 *||24 sept. 2004||1 déc. 2005||Spence Paul A||Tissue fastening systems and methods utilizing magnetic guidance|
|US20060069429 *||24 sept. 2004||30 mars 2006||Spence Paul A||Tissue fastening systems and methods utilizing magnetic guidance|
|DE102009036365A1 *||6 août 2009||10 févr. 2011||Norbert Lemke||Surgical clip for sealing intracorporal vessel or tissue opening, has jaw supported in longitudinal movable manner relative to connection element and lockable using clamping force along connection element in self-locking manner|
|Classification aux États-Unis||227/175.1, 128/898|
|Classification internationale||A61B17/04, A61B17/064, A61B19/00, A61B17/00, A61F2/24, A61M, A61B17/068|
|Classification coopérative||A61B2017/0649, A61B17/0469, A61B2017/0472, A61B17/0487, A61B17/0643, A61B2017/0462, A61B17/0644, A61B17/00234, A61B2017/0496, A61B2017/0464, A61B2017/00243, A61B2017/00867, A61B2017/0417, A61B2017/00349|
|Classification européenne||A61B17/064D, A61B17/04E, A61B17/00E|
|20 sept. 2012||AS||Assignment|
Owner name: MITRALIGN INC., MASSACHUSETTS
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION;REEL/FRAME:028992/0635
Effective date: 20120907